Pages

▼

Wednesday, February 3, 2010

CF Investigational Drug VX-809 Shows Encouraging Results in Phase 2a Trial - CF Foundation

CF Investigational Drug VX-809 Shows Encouraging Results in Phase 2a Trial - CF Foundation

Read about this amazing new drug in the works for Delta 508 (ayla's CF mutation)
at

1 comment:

  1. AnonymousFebruary 4, 2010 at 8:52 PM

    So excited! Praise the Lord!

    Praying and working for a cure!

    Love ya'll!
    Nana

    ReplyDelete